| U.S. Congressional Tipoffs Involving Kentucky Newsletter for Wednesday July 24, 2024 ( 5 items ) |
|
Hearing Wrap Up: Oversight Committee Exposes How PBMs Undermine Patient Health and Increase Drug Costs
WASHINGTON, July 24 -- Rep. James Comer, R-Kentucky, chairman of the House Oversight and Accountability Committee, issued the following news release on July 23, 2024:
Today, the House Committee on Oversight and Accountability held a hearing titled "The Role of Pharmacy Benefit Managers in Prescription Drug Markets Part III: Transparency and Accountability." At the hearing, Republicans and Democrats pressed Pharmacy Benefit Manager (PBM) chief executives on their role in rising prescription drug
more
House Oversight Committee Chairman Comer Issues Statement on Secret Service Director Cheatle Resignation
WASHINGTON, July 24 -- Rep. James Comer, R-Kentucky, chairman of the House Oversight and Accountability Committee, issued the following news release on July 23, 2024:
House Committee on Oversight and Accountability Chairman James Comer (R-Ky.) issued the following statement after U.S. Secret Service Director Kimberly Cheatle announced her resignation:
"The Oversight Committee's hearing resulted in Director Cheatle's resignation and there will be more accountability to come. The Secret Service
more
House Oversight Committee Chairman Comer Releases Report on PBMs Harmful Pricing Tactics & Role in Rising Health Care Costs
WASHINGTON, July 24 -- Rep. James Comer, R-Kentucky, chairman of the House Oversight and Accountability Committee, issued the following news release on July 23, 2024:
Today, House Committee on Oversight and Accountability Chairman James Comer (R-Ky.) issued a report outlining how the three largest Pharmacy Benefit Managers (PBMs) --CVS Caremark, Express Scripts, and OptumRx--have monopolized the pharmaceutical marketplace by deploying deliberate, anticompetitive pricing tactics that are raising
more
House Oversight Committee Chairman Comer: Pharmacy Benefit Managers Must Be Held Accountable for Role in Rising Drug Prices
WASHINGTON, July 24 -- Rep. James Comer, R-Kentucky, chairman of the House Oversight and Accountability Committee, issued the following news release on July 23, 2024:
Today, House Committee on Oversight and Accountability Chairman James Comer (R-Ky.) delivered opening remarks at a full committee hearing titled "The Role of Pharmacy Benefit Managers in Prescription Drug Markets Part III: Transparency and Accountability." In his opening statement, Chairman Comer detailed how the House Oversight C
more
House Oversight Subcommittee on Government Operations Chairman Sessions: Transparency & Efficiency Within CIGIE is Critical to Supporting Inspector General Offices
WASHINGTON, July 24 -- Rep. Pete Sessions, R-Kentucky, chairman of the House Oversight and Accountability Subcommittee on Government Operations and the Federal Workforce, issued the following news release on July 23, 2024:
Subcommittee on Government Operations and the Federal Workforce Chairman Pete Sessions (R-Texas) today delivered opening remarks at a hearing titled "Oversight of the Council of the Inspectors General on Integrity and Efficiency." Chairman Sessions discussed the Subcommittee'
more
|
Sign up to Receive this newsletter every day via email.